KLOW Blend 80mg (GHK-Cu, BPC-157, TB-500, KPV)
Welcome to the official VitalisLabs UK product page for KLOW 80mg—the premier 4-in-1 multi-peptide research matrix. Engineered for comprehensive cell-migration, extracellular matrix, and anti-inflammatory pathway studies, this co-lyophilized 80mg vial unites four of the most widely cited research peptides into a single fixed-ratio formulation.
Buy KLOW 80mg UK — Premium 4-in-1 Research Formulation
When conducting multi-variable tissue recovery and cellular signaling models, maintaining exact mass ratios is essential. When you buy KLOW 80mg UK products directly from VitalisLabs, each blue lyophilized vial is freeze-dried under strict parameters to guarantee component stability and long-term analytical integrity.
+-----------------------------------------------------------------------+
| PRODUCT SPECIFICATION OVERVIEW |
| |
| * Product Identifier: VL-KLOW-80 |
| * Total Mass per Vial: 80mg total co-lyophilized peptide |
| * Composition Breakdown: |
| - GHK-Cu (Copper Tripeptide): 50mg |
| - BPC-157 (Pentadecapeptide): 10mg |
| - TB-500 (Thymosin Beta-4 Fragment): 10mg |
| - KPV (alpha-MSH Tripeptide Fragment): 10mg |
| * Purity Level: >99% (HPLC Verified per component) |
| * Appearance: Characteristic Light Blue Powder |
| |
| [ Download Batch COA Certificate ] ---> Opens PDF |
+-----------------------------------------------------------------------+
What Is Inside the KLOW Peptide Blend?
The KLOW 80mg formulation combines four distinct peptides to allow simultaneous observation across multiple cellular pathways:
-
GHK-Cu (50mg): A naturally occurring copper-bound tripeptide studied extensively for collagen and elastin synthesis, fibroblast migration, and extracellular matrix (ECM) remodeling. Gives the powder its characteristic blue hue.
-
BPC-157 (10mg): A synthetic 15-amino acid peptide investigated for cytoprotection, growth-factor upregulation, and VEGF-driven angiogenic signaling.
-
TB-500 (10mg): Synthetic actin-binding peptide fragment (Thymosin $\beta_4$) studied for actin sequestration, cell motility, and structural tissue repair.
-
KPV (10mg): A targeted tripeptide (Lys-Pro-Val) derived from the C-terminus of $\alpha$-MSH, researched for receptor-independent NF-$\kappa$B and cytokine signaling modulation.
KLOW vs GLOW Peptide Blends: The Key Difference
A common query in tissue recovery literature involves comparing KLOW vs GLOW:
-
GLOW Blend: Combines 3 structural and regenerative compounds (GHK-Cu, BPC-157, and TB-500) focused on matrix remodeling and cellular repair.
-
KLOW Blend: Retains the core 3 compounds of GLOW but incorporates KPV (10mg). The addition of KPV introduces a dedicated cytokine-signalling and NF-$\kappa$B modulation component to the research matrix.
Technical Specifications: KLOW 80mg
| Component | Sequence / Structure | Class / Type | Mass Share |
| GHK-Cu | Gly-His-Lys ($\text{Cu}^{2+}$ complex) | Copper-binding Tripeptide | 50mg (62.5%) |
| BPC-157 | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Pentadecapeptide | 10mg (12.5%) |
| TB-500 | LKKTETQ domain fragment | Actin-binding peptide | 10mg (12.5%) |
| KPV | Lys-Pro-Val | $\alpha$-MSH fragment tripeptide | 10mg (12.5%) |
Reconstitution & Handling Guidelines
-
Storage Prior to Preparation: Store lyophilized vials in a dry, dark environment at -20°C.
-
Reconstitution Volume: Reconstitute with 3.0mL of sterile bacteriostatic water to achieve a working concentration of ~26.7mg/mL total blend.
-
Handling: Add diluent along the glass wall and allow the powder to dissolve passively—do not agitate or shake violently.
-
Post-Reconstitution: Store solution refrigerated between 2°C and 8°C.
Compliance Disclaimer: All KLOW peptide blend UK products supplied by VitalisLabs are strictly intended for laboratory in vitro testing, analytical reference, and research applications. They are not intended for human consumption, clinical trials, or therapeutic use.







Reviews
There are no reviews yet.